Volume 71, Issue 6, Pages (March 2007)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 4, Pages (April 2002)
Advertisements

Volume 63, Issue 2, Pages (February 2003)
Volume 73, Issue 11, Pages (June 2008)
Volume 59, Issue 5, Pages (May 2001)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 60, Issue 3, Pages (September 2001)
Volume 56, Issue 6, Pages (December 1999)
Volume 64, Issue 5, Pages (November 2003)
Volume 72, Issue 3, Pages (August 2007)
Volume 83, Issue 3, Pages (March 2013)
Volume 75, Issue 3, Pages (February 2009)
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Volume 75, Issue 2, Pages (January 2009)
Interstitial tonicity controls TonEBP expression in the renal medulla
Volume 73, Issue 4, Pages (February 2008)
Autophagy in proximal tubules protects against acute kidney injury
Hypertonicity stimulates PGE2 signaling in the renal medulla by promoting EP3 and EP4 receptor expression  Jeong-Ah Kim, Mee Rie Sheen, Sang Do Lee, Ju-Young.
Volume 62, Issue 5, Pages (November 2002)
Volume 69, Issue 12, Pages (June 2006)
Volume 67, Issue 6, Pages (June 2005)
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 54, Issue 3, Pages (September 1998)
Intestinal phosphate absorption in a model of chronic renal failure
Volume 56, Issue 6, Pages (December 1999)
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Volume 64, Issue 5, Pages (November 2003)
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 61, Issue 3, Pages (March 2002)
Volume 72, Issue 3, Pages (August 2007)
Volume 70, Issue 6, Pages (September 2006)
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Mitogen-activated protein kinase upregulation reduces renal D1 receptor affinity and G- protein coupling in obese rats  A.A. Banday, F.R. Fazili, A. Marwaha,
Volume 73, Issue 12, Pages (June 2008)
COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex  Klaus Höcherl, Christoph Schmidt,
Volume 63, Issue 2, Pages (February 2003)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 2, Pages (August 1999)
Volume 73, Issue 5, Pages (March 2008)
Volume 63, Issue 5, Pages (May 2003)
Fructose intake as a risk factor for kidney stone disease
Volume 61, Issue 4, Pages (April 2002)
Volume 85, Issue 3, Pages (March 2014)
Volume 85, Issue 4, Pages (April 2014)
The pathological role of Bax in cisplatin nephrotoxicity
Volume 58, Issue 2, Pages (August 2000)
Volume 54, Issue 4, Pages (October 1998)
Volume 74, Issue 5, Pages (September 2008)
Erythropoietin, progenitors, and repair
Volume 79, Issue 2, Pages (January 2011)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Role of the T-cell receptor in kidney ischemia–reperfusion injury
Volume 73, Issue 3, Pages (February 2008)
Andrea Schreiber, Franziska Theilig, Frank Schweda, Klaus Höcherl 
Volume 60, Issue 6, Pages (December 2001)
Increased endothelin-1 expression in the kidney in hypercalcemic rats
Volume 67, Issue 4, Pages (April 2005)
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Volume 88, Issue 6, Pages (December 2015)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 69, Issue 1, Pages (January 2006)
Volume 69, Issue 2, Pages (January 2006)
Volume 71, Issue 9, Pages (May 2007)
Volume 70, Issue 10, Pages (November 2006)
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Presentation transcript:

Volume 71, Issue 6, Pages 539-547 (March 2007) Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion- induced qacute renal failure  T. Matsuzaki, H. Watanabe, K. Yoshitome, T. Morisaki, A. Hamada, H. Nonoguchi, Y. Kohda, K. Tomita, K. Inui, H. Saito  Kidney International  Volume 71, Issue 6, Pages 539-547 (March 2007) DOI: 10.1038/sj.ki.5002104 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Changes in body weight and the level of BUN and SCr in control and ischemic rats with/without intake of cobalt. (a) Body weight of killing over body weight of operation, (b) BUN and (c) SCr after sham operation (open column) or I/R injury (closed column). Each column represents the mean±s.e.m. for three to eight rats. *P<0.05, **P<0.01, significantly different from control rats at same period. #P<0.05, ##P<0.01, significantly different from rats without cobalt intake at the same period. Kidney International 2007 71, 539-547DOI: (10.1038/sj.ki.5002104) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Histological alteration of the kidneys of control and ischemic rats with or without cobalt intake at 48h after ischemia. (a) Control rats, (b) control rats with cobalt intake, (c) ischemic rats, (d) ischemic rats with cobalt intake, (e) outer stripe of ischemic rats, and (f) outer stripe of ischemic rats with cobalt intake. (a–d) Hematoxylin–eosin staining low magnification; (e and f) hematoxylin–eosin staining high magnification. Tubular injury of (g) outer stripe and (h) inner stripe of outer medulla in I/R rats with or without cobalt intake was graded with an arbitrary score of 0–3. The horizontal solid lines indicate the median. Statistical analyses were performed using the Mann–Whitney's test. I/R caused tubular damage to the outer stripe of outer medulla. Cobalt intake reduces tubular damage induced by I/R. Kidney International 2007 71, 539-547DOI: (10.1038/sj.ki.5002104) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Serum IS concentration in control and ischemic rats with and without cobalt intake. (a) High-performance liquid chromatography analysis of serum to determine the concentration of IS after sham operation (open column) or I/R injury (closed column). Each column represents the mean±s.e.m. for three to eight rats. **P<0.01, significantly different from control rats at the same period. ##P<0.01, significantly different from rats without cobalt intake over the same period. Correlation between (b) BUN or (c) SCr and serum IS concentration. Kidney International 2007 71, 539-547DOI: (10.1038/sj.ki.5002104) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 mRNA expression of organic anion transporters and rMdr1a in ischemic rat kidney. Relative mRNA expression levels of (a) rOAT1, (b) rOAT3 and (c) rMdr1a in control (open column) and ischemic rats (closed column) with and without cobalt intake. The expression level in the control at 6h was set at 1.0. Each column represents the mean±s.e.m. for three to eight rats. *P<0.05, **P<0.01, significantly different from control rats at the same period. Kidney International 2007 71, 539-547DOI: (10.1038/sj.ki.5002104) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 Immunoblots of kidneys from control and ischemic rats with or without cobalt intake 48h after ischemia. (a) Antiserum specific for rOAT1, rOAT3, P-glycoprotein, Na+/K+-ATPase, and β-actin were used as primary antibodies. (b) The ratio of rOAT1, rOAT3, P-glycoprotein, and Na+/K+-ATPase density to β-actin density. The values for control rats without cobalt intake were arbitrarily defined as 100%. Each bar represents the mean±s.e.m. for three rats in each group. *P<0.05, **P<0.01, significantly different from control rats with or without cobalt intake; #P<0.05, significantly different from ischemic rats without cobalt intake. Kidney International 2007 71, 539-547DOI: (10.1038/sj.ki.5002104) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 6 Renal uptake of PAH and ES in control and ischemic rats with or without cobalt intake. (a) PAH and (b) ES accumulation by renal slices of control and ischemic rats at 48h after ischemia. Renal slices from control (○) and ischemic rats (•) were incubated at 37°C in incubation buffer containing 5μM [14C]PAH or 5μM [3H]ES, for the period indicated. D-[3H]Mannitol or [14C]mannitol was used to estimate the extracellular trapping and nonspecific uptake of [14C]PAH or [3H]ES, respectively. Each point represents the mean±s.e.m. for three to five slices. *P<0.05, **P<0.01, significantly different from control rats at same period. The renal uptake clearance of (c) PAH and (d) ES in control and ischemic rats with or without cobalt intake at 48h after ischemia. Renal slices from rats were incubated at 37°C in incubation buffer containing 5μM [14C]PAH or 5μM [3H]ES, for 60min. *P<0.05, **P<0.01, significantly different from control rats with or without cobalt intake; #P<0.05, significantly different from ischemic rats without cobalt intake. Kidney International 2007 71, 539-547DOI: (10.1038/sj.ki.5002104) Copyright © 2007 International Society of Nephrology Terms and Conditions